Functional analysis of MITF gene mutations associated with Waardenburg syndrome type 2

FEBS Lett. 2012 Nov 30;586(23):4126-31. doi: 10.1016/j.febslet.2012.10.006. Epub 2012 Oct 23.

Abstract

MITF mutations results in an abnormal melanocyte development and lead to Waardenburg syndrome type 2 (WS2). Here, we analyzed the in vitro activities of two recently identified WS2-associated MITF mutations (p.R217I and p.T192fsX18). The R217I MITF retained partial activity, normal DNA-binding ability and nuclear distribution, whereas the T192fsX18 MITF failed to activate TYR promoter and showed aberrant subcellular localization which may be caused by deletion of nuclear localization signal (NLS) at aa 213-218 (ERRRRF). These results suggest that haploinsufficiency may be the underlying mechanism for the mild phenotypes of WS2 caused by these two mutations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western
  • Cell Line, Tumor
  • Fluorescent Antibody Technique
  • Humans
  • Mice
  • Microphthalmia-Associated Transcription Factor / genetics*
  • Microphthalmia-Associated Transcription Factor / metabolism*
  • Mutation
  • NIH 3T3 Cells
  • Waardenburg Syndrome / genetics*
  • Waardenburg Syndrome / metabolism

Substances

  • Microphthalmia-Associated Transcription Factor